Breath analyser, saliva testers, drug testing, and biosensor markets to hit $7 billion by 2020

Reportstack has published a new Wintergreen study - Alcohol Breath Analyser And Drug Testing Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2014 to 2020.

Worldwide markets are poised to achieve significant growth as law enforcement and companies get more businesses test for substance abuse.

Controls are likely to be put more in place going forward as the dangers are more commonly recognized and as the ability to detect users becomes more available at an affordable price. The drug testing segment was 29% of the drug and alcohol abuse detection market in 2013 and this is set to grow to 66% of the market by 2020. The report indicates that markets currently at $699 million will reach $7 billion by 2020.

Breath and saliva contain markers that can be used to monitor alcohol abuse, drug abuse, and the health status of patients. In the US nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drink driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organisations, vehicle owners and others to install portable breath analysers at their work places.

In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices.

The alcohol testing segment accounted for the largest share of the market owing to the rising trend of road accidents and other causalities due to excessive alcohol consumption. The tuberculosis detection market is anticipated to show highest growth of 44.7% from 2013 to 2019. The growth in this segment is attributed to increasing incidence of tuberculosis especially in developing countries and increasing demand for a non-invasive surgery and accurate screening tool.

According to Susan Eustis, lead author of the WinterGreen Research team: "There are the issues of increased absenteeism and sickness, more frequent lateness for work, and increased risk of theft of property and cash from the company and other staff. Each of these carries a cost."